Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy

Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy

Abstract Background Breast cancer is one of the most lethal cancers in women. Despite significant advances in the diagnosis and treatment of breast cancer, many patients still succumb to this disease, and thus, novel effective treatments are urgently needed. Natural product coumarin has been broadly...

Полное описание

Библиографические подробности
Главные авторы:	Sujie Zhu, Wenjing Zhu, Kaihua Zhao, Jie Yu, Wenxia Lu, Rui Zhou, Shule Fan, Weikaixin Kong, Feifei Yang, Peipei Shan
Формат:	Статья
Язык:	English
Опубликовано:	BMC 2024-07-01
Серии:	Cell Communication and Signaling
Предметы:	Breast cancer Metastasis Tumor growth Histone deacetylases inhibitor Coumarins FOSL2
Online-ссылка:	https://doi.org/10.1186/s12964-024-01733-4

Схожие документы

The Role of HDACs as Leukemia Therapy Targets using HDI
по: Ahmad Ahmadzadeh, и др.
Опубликовано: (2016-02-01)

KLF14 inhibits tumor progression via FOSL1 in glioma
по: Xiaohua Wang, и др.
Опубликовано: (2025-03-01)

Design, Synthesis and Biological Evaluation of Novel Coumarin-Based Hydroxamate Derivatives as Histone Deacetylase (Hdac) Inhibitors with Antitumor Activities
по: Feifei Yang, и др.
Опубликовано: (2019-07-01)

Influence of FOSL1 Inhibition on Vascular Calcification and ROS Generation through Ferroptosis via P53-SLC7A11 Axis
по: Sisi Shao, и др.
Опубликовано: (2023-02-01)

Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
по: Donglu Wu, и др.
Опубликовано: (2020-11-01)

NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1
по: Carolina Marques, и др.
Опубликовано: (2021-08-01)

All for one and FOSL1 for all: FOSL1 at the crossroads of lung and pancreatic cancer driven by mutant KRAS
по: Adrian Vallejo, и др.
Опубликовано: (2017-05-01)

FOSL1 promotes tumor growth and invasion in ameloblastoma
по: Gan Xiong, и др.
Опубликовано: (2022-09-01)

Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies
по: Wanli Zhang, и др.
Опубликовано: (2025-02-01)

Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases
по: Anton Frühauf, и др.
Опубликовано: (2021-08-01)

PMAIP1 regulates the progression of follicular thyroid carcinoma through the Wnt3/FOSL1 pathway
по: Haobo Wang, и др.
Опубликовано: (2025-01-01)

Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder cancer progression through the WNT pathway
по: Mingyue Tan, и др.
Опубликовано: (2023-11-01)

HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
по: Jie Wang, и др.
Опубликовано: (2022-12-01)

FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancer
по: Qingling He, и др.
Опубликовано: (2024-11-01)

FOSL2 activates TGF‐β1‐mediated GLUT1/mTOR signaling to promote diabetic kidney disease
по: Xuelin He, и др.
Опубликовано: (2025-02-01)

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
по: Saikat Dewanjee, и др.
Опубликовано: (2021-05-01)

The Importance of the “Time Factor” for the Evaluation of Inhibition Mechanisms: The Case of Selected HDAC6 Inhibitors
по: Edoardo Cellupica, и др.
Опубликовано: (2023-07-01)

Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
по: Jacob King, и др.
Опубликовано: (2021-11-01)

HDAC3 and HDAC8 are required for cilia assembly and elongation
по: Seon-ah Park, и др.
Опубликовано: (2019-08-01)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
по: Elizabeth A. Thomas
Опубликовано: (2014-05-01)

HDAC1-mediated deacetylation of HIF1α prevents atherosclerosis progression by promoting miR-224-3p-mediated inhibition of FOSL2
по: Hao Wang, и др.
Опубликовано: (2021-03-01)

FOSL1 drives the malignant progression of pancreatic cancer cells by regulating cell stemness, metastasis and multidrug efflux system
по: Xiaolong Liu, и др.
Опубликовано: (2025-03-01)

MiR-33a targets FOSL1 and EN2 as a clinical prognostic marker for sarcopenia by glioma
по: Wei Wang, и др.
Опубликовано: (2022-08-01)

Design of Fluorescent Coumarin-Hydroxamic Acid Derivatives as Inhibitors of HDACs: Synthesis, Anti-Proliferative Evaluation and Docking Studies
по: Santiago García, и др.
Опубликовано: (2020-11-01)

Current HDAC Inhibitors in Clinical Trials
по: Elisabetta Di Bello, и др.
Опубликовано: (2022-05-01)

Development of Coumarin-Based Hydroxamates as Histone Deacetylase Inhibitors with Antitumor Activities
по: Na Zhao, и др.
Опубликовано: (2020-02-01)

CircCRIM1 promotes nasopharyngeal carcinoma progression via the miR-34c-5p/FOSL1 axis
по: Weifeng He, и др.
Опубликовано: (2022-04-01)

Identification of isoform-selective hydroxamic acid derivatives that potently reactivate HIV from latency
по: Elleard F.W. Heffern, и др.
Опубликовано: (2019-04-01)

Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin–HDAC Inhibitor Hybrids as Multitarget Drugs
по: Lukas von Bredow, и др.
Опубликовано: (2022-03-01)

Exploration of quinazoline-tethered hydroxamic acid derivatives as HDAC inhibitors for anticancer activity: Design, synthesis, molecular docking, and biological evaluation
по: Shweta Mishra, и др.
Опубликовано: (2024-01-01)

Molecular Docking Simulations on Histone Deacetylases (HDAC)-1 and -2 to Investigate the Flavone Binding
по: Bernardina Scafuri, и др.
Опубликовано: (2020-12-01)

Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
по: Beatriz Silva Urias, и др.
Опубликовано: (2022-10-01)

Overexpression of FRA1 (<i>FOSL1</i>) Leads to Global Transcriptional Perturbations, Reduced Cellular Adhesion and Altered Cell Cycle Progression
по: Wuroud Al-khayyat, и др.
Опубликовано: (2023-09-01)

Hydroxamic Acid as a Potent Metal-Binding Group for Inhibiting Tyrosinase
по: Joonhyeok Choi, и др.
Опубликовано: (2022-01-01)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
по: Liesbeth Everix, и др.
Опубликовано: (2023-02-01)

Multimodal nanoparticle‐containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammation
по: Nhu Truong, и др.
Опубликовано: (2024-01-01)

HDAC6 Enhances Endoglin Expression through Deacetylation of Transcription Factor SP1, Potentiating BMP9-Induced Angiogenesis
по: Chen Sun, и др.
Опубликовано: (2024-03-01)

Design, synthesis, and biological evaluation of substituted benzyl-triazolopyridine derivatives as non-hydroxamate based HDAC8 inhibitors
по: N.V.M. Rao Bandaru, и др.
Опубликовано: (2025-04-01)

Design and synthesis of diazine-based panobinostat analogues for HDAC8 inhibition
по: Sivaraman Balasubramaniam, и др.
Опубликовано: (2020-04-01)

The replication timing program in the hands of two HDACs
по: Kazumasa Yoshida, и др.
Опубликовано: (2014-07-01)